OncLive: Dr. Mesa on Emerging Therapies in Myelofibrosis
September 24, 2020
Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses emerging therapies in myelofibrosis. Watch the interview.
Category
September 24, 2020
Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses emerging therapies in myelofibrosis. Watch the interview.
September 23, 2020
Alvaro Moreira, MD, Neonatology, was interviewed regarding the severe heart damage some children experience after a rare illness linked to COVID-19. Read and watch the story.
September 23, 2020
Alvaro Moreira, MD, Neonatology, was interviewed regarding the severe heart damage some children experience after a rare illness linked to COVID-19. Read and watch the story.
September 23, 2020
UT Health San Antonio researchers developed a survey that primary care providers, allergists, dermatologists and other specialists can incorporate into patient visits to screen for chemical intolerance. Read the story.
September 23, 2020
UT Health San Antonio researchers developed a survey that primary care providers, allergists, dermatologists and other specialists can incorporate into patient visits to screen for chemical intolerance. Read the story.
September 22, 2020
UT Health San Antonio researchers developed a survey that primary care providers, allergists, dermatologists and other specialists can incorporate into patient visits to screen for chemical intolerance. Read the story.